| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $30.7M | -8.5% |
| Cost of Revenue | $12.8M | -11.5% |
| Gross Profit | $17.9M | -6.3% |
| R&D Expense | $421K | -52.3% |
| SG&A Expense | $10.2M | -9.9% |
| Operating Income | -$4.7M | +49.2% |
| Pre-tax Income | -$6.2M | +39.1% |
| Income Tax | $12K | +107.1% |
| Net Income | -$6.3M | +37.9% |
| EPS (Basic) | -$1.35 | +49.1% |
| EPS (Diluted) | -$1.35 | +49.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.9M | +9.0% |
| Accounts Receivable | $4.1M | -21.5% |
| Inventory | $2.8M | +25.3% |
| Current Assets | $15.6M | -6.0% |
| Total Assets | $30.5M | -15.6% |
| Current Liabilities | $26.7M | +82.8% |
| Long-term Debt | $15.3M | +2.3% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.8M | -1586.2% |
| Capital Expenditures | $1.5M | -10.3% |
| Investing Cash Flow | -$1.5M | +10.3% |
| Financing Cash Flow | $3.6M | +85.9% |
| Free Cash Flow | -$4.3M | -194.3% |
| $27.6M |
| -11.5% |
| Stockholders' Equity | $2.9M | -41.5% |